[Hematological problems in acquired immunodeficiency syndromes (AIDS)]

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.

ESMO open·2022

Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Gene expression of INPP5F as an independent prognostic marker in fludarabine-based therapy of chronic lymphocytic leukemia.

Blood cancer journal·2015

JAK inhibitors: pharmacology and clinical activity in chronic myeloprolipherative neoplasms.

Current medicinal chemistry·2013

A targeted therapy for protein and lipid kinases in chronic lymphocytic leukemia.

Current medicinal chemistry·2012

Ciprofloxacin prophylaxis for patients undergoing high-dose chemotherapy and autologous stem cell transplantation (ASCT) - a single-center experience.

Advances in medical sciences·2012

[Risk of transmission of blood-derived pathogens by transfusion in Poland].

Acta haematologica Polonica·2020

[Emerging infectious diseases in the context of blood safety].

Acta haematologica Polonica·2020

<i>Quo Vadis</i> medycyno regeneracyjna?: Quo Vadis Regenerative Medicine?

Acta haematologica Polonica·2013

[RHnull syndrome--diagnostic and therapeutic problems].

Acta haematologica Polonica·1996

[Unclassified chronic myeloproliferative Ph(-); i(17q); +8 syndrome with mixed myelo-megakaryoblastic crisis--case report].

Acta haematologica Polonica·1996

Acute myelofibrosis in children: report on two cases.

Acta haematologica Polonica·1996

Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.

Case reports in dermatological medicine·2026

Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.

Frontiers in endocrinology·2026

Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.

Kidney diseases (Basel, Switzerland)·2026

Diffuse Large B-cell Lymphoma Initially Managed As Secondary Immune Thrombocytopenia: A Case Report.

Cureus·2026

Adverse pregnancy outcome associations among women prior to a diagnosis of systemic lupus erythematosus.

Frontiers in lupus·2026

Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.

Frontiers in cell and developmental biology·2026

Related Experiment Videos

[Hematological problems in acquired immunodeficiency syndromes (AIDS)]

Related Concept Videos

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.

Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.

Gene expression of INPP5F as an independent prognostic marker in fludarabine-based therapy of chronic lymphocytic leukemia.

JAK inhibitors: pharmacology and clinical activity in chronic myeloprolipherative neoplasms.

A targeted therapy for protein and lipid kinases in chronic lymphocytic leukemia.

Ciprofloxacin prophylaxis for patients undergoing high-dose chemotherapy and autologous stem cell transplantation (ASCT) - a single-center experience.

[Risk of transmission of blood-derived pathogens by transfusion in Poland].

[Emerging infectious diseases in the context of blood safety].

<i>Quo Vadis</i> medycyno regeneracyjna?: Quo Vadis Regenerative Medicine?

[RHnull syndrome--diagnostic and therapeutic problems].

[Unclassified chronic myeloproliferative Ph(-); i(17q); +8 syndrome with mixed myelo-megakaryoblastic crisis--case report].

Acute myelofibrosis in children: report on two cases.

Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.

Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.

Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.

Diffuse Large B-cell Lymphoma Initially Managed As Secondary Immune Thrombocytopenia: A Case Report.

Adverse pregnancy outcome associations among women prior to a diagnosis of systemic lupus erythematosus.

Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.

Related Experiment Videos

[Hematological problems in acquired immunodeficiency syndromes (AIDS)]

Related Concept Videos

Related Articles